| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |